PUBLISHER: Grand View Research | PRODUCT CODE: 1869701
PUBLISHER: Grand View Research | PRODUCT CODE: 1869701
The global peripheral vascular devices market size was estimated at USD 10.44 billion in 2024 and is projected to reach USD 16.90 billion by 2033, growing at a CAGR of 5.3% from 2025 to 2033. The rising prevalence of peripheral arterial disease (PAD) is significantly driving the growth of the peripheral vascular devices market.
PAD has a significantly high prevalence in both developed and emerging economies globally. For instance, according to a study published in the American Heart Association Journals in June 2023, more than 12 million Americans had PAD, with global prevalence reaching around 200 million people. Similarly, according to the Australian Institute of Health and Welfare data article published in June 2024, PAD was recorded in around 59,100 hospitalizations in 2020-21.
The growth of the peripheral vascular devices market is significantly influenced by the increasing number of clinical trials and studies focusing on vascular health. Clinical trials allow researchers to evaluate the safety and efficacy of new devices and techniques in treating peripheral vascular diseases (PVD). For instance, in March 2024, BD started the AGILITY study by enrolling its first patient to assess the safety and efficacy of the BD Vascular Covered Stent for the treatment of PAD. Three hundred fifteen patients likely to participate in this international, multi-center clinical trial at 40 locations in the U.S., Europe, Australia, and New Zealand. The study aims to address critical unmet needs in the treatment of PAD. These trials validate current technologies and give way to new treatments that meet unmet medical needs as they grow.
Introducing novel products that address the evolving needs of patients and healthcare providers significantly contributes to market growth. The launch of these products includes cutting-edge technologies such as drug-eluting capabilities, bioresorbable materials, and others. For instance, in December 2023, Terumo India launched Ultimaster Nagomi, an advanced drug-eluting coronary stent system designed for complex percutaneous coronary interventions (PCI). The stent features an optimized delivery system, expanded size range, and increased overexpansion capability, allowing it to adapt to challenging anatomies. Ultimate Nagomi aims to improve patient outcomes by enabling customized stent selection for small to large coronary arteries.
Moreover, in May 2024, Abbott introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, designed to enhance treatment for patients with blocked coronary arteries. This next-generation stent features an improved design, a new delivery system, and specialized sizes to address complex cases effectively. XIENCE Sierra aims to provide greater flexibility and precision for interventional cardiologists, making it easier to navigate challenging blockages. This focus on innovation addresses clinical challenges and enhances procedural efficiency, leading to increased adoption of these devices among healthcare professionals.
Global Peripheral Vascular Devices Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global peripheral vascular devices market report based on type, application, end use, and region: